166 related articles for article (PubMed ID: 15029233)
41. Lentiviral siRNAs targeting multiple highly conserved RNA sequences of human immunodeficiency virus type 1.
Chang LJ; Liu X; He J
Gene Ther; 2005 Jul; 12(14):1133-44. PubMed ID: 15750613
[TBL] [Abstract][Full Text] [Related]
42. DNA transposons for modification of human primary T lymphocytes.
Huang X; Wilber A; McIvor RS; Zhou X
Methods Mol Biol; 2009; 506():115-26. PubMed ID: 19110623
[TBL] [Abstract][Full Text] [Related]
43. Regulated and constitutive expression of anti-inflammatory cytokines by nontransforming herpesvirus saimiri vectors.
Wieser C; Stumpf D; Grillhösl C; Lengenfelder D; Gay S; Fleckenstein B; Ensser A
Gene Ther; 2005 Mar; 12(5):395-406. PubMed ID: 15647772
[TBL] [Abstract][Full Text] [Related]
44. Selective gene transfer to T lymphocytes using coreceptor-specific [MLV(HIV)] pseudotype vectors in a transgenic mouse model.
Schüle S; Steidl S; Panitz S; Coulibaly C; Kalinke U; Cichutek K; Schweizer M
Virology; 2006 Jul; 351(1):237-47. PubMed ID: 16650881
[TBL] [Abstract][Full Text] [Related]
45. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
46. Activation conditions determine susceptibility of murine primary T-lymphocytes to retroviral infection.
Hagani AB; Rivière I; Tan C; Krause A; Sadelain M
J Gene Med; 1999; 1(5):341-51. PubMed ID: 10738551
[TBL] [Abstract][Full Text] [Related]
47. Lentiviral vectors pseudotyped with murine ecotropic envelope: increased biosafety and convenience in preclinical research.
Schambach A; Galla M; Modlich U; Will E; Chandra S; Reeves L; Colbert M; Williams DA; von Kalle C; Baum C
Exp Hematol; 2006 May; 34(5):588-92. PubMed ID: 16647564
[TBL] [Abstract][Full Text] [Related]
48. Small nuclear RNAs encoded by Herpesvirus saimiri upregulate the expression of genes linked to T cell activation in virally transformed T cells.
Cook HL; Lytle JR; Mischo HE; Li MJ; Rossi JJ; Silva DP; Desrosiers RC; Steitz JA
Curr Biol; 2005 May; 15(10):974-9. PubMed ID: 15916956
[TBL] [Abstract][Full Text] [Related]
49. Lentiviral transduction of immune cells.
Swainson L; Mongellaz C; Adjali O; Vicente R; Taylor N
Methods Mol Biol; 2008; 415():301-20. PubMed ID: 18370162
[TBL] [Abstract][Full Text] [Related]
50. Comparison of murine leukemia virus, human immunodeficiency virus, and adeno-associated virus vectors for gene transfer in multiple myeloma: lentiviral vectors demonstrate a striking capacity to transduce low-proliferating primary tumor cells.
De Vos J; Bagnis C; Bonnafoux L; Requirand G; Jourdan M; Imbert MC; Jourdan E; Rossi JF; Mannoni P; Klein B
Hum Gene Ther; 2003 Dec; 14(18):1727-39. PubMed ID: 14670124
[TBL] [Abstract][Full Text] [Related]
51. [*OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Fu Chan Ke Za Zhi; 2006 May; 41(5):333-8. PubMed ID: 16762191
[TBL] [Abstract][Full Text] [Related]
52. Using lentiviral vectors for efficient pancreatic cancer gene therapy.
Ravet E; Lulka H; Gross F; Casteilla L; Buscail L; Cordelier P
Cancer Gene Ther; 2010 May; 17(5):315-24. PubMed ID: 19911032
[TBL] [Abstract][Full Text] [Related]
53. Enhanced transduction of antigen-stimulated T lymphocytes with recombinant retroviruses concentrated by centrifugal filtration.
Kinyanjui MW; Ramos-Barbón D; Villeneuve A; Fixman ED
J Immunol Methods; 2006 Jul; 314(1-2):80-9. PubMed ID: 16842814
[TBL] [Abstract][Full Text] [Related]
54. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin.
Li S; Kimura E; Fall BM; Reyes M; Angello JC; Welikson R; Hauschka SD; Chamberlain JS
Gene Ther; 2005 Jul; 12(14):1099-108. PubMed ID: 15759015
[TBL] [Abstract][Full Text] [Related]
55. A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes.
Thaler S; Schnierle BS
Mol Ther; 2001 Sep; 4(3):273-9. PubMed ID: 11545619
[TBL] [Abstract][Full Text] [Related]
56. Generation of lentivirus vectors using recombinant baculoviruses.
Lesch HP; Turpeinen S; Niskanen EA; Mähönen AJ; Airenne KJ; Ylä-Herttuala S
Gene Ther; 2008 Sep; 15(18):1280-6. PubMed ID: 18463689
[TBL] [Abstract][Full Text] [Related]
57. Lentivirus-mediated RNA interference of DC-SIGN expression inhibits human immunodeficiency virus transmission from dendritic cells to T cells.
Arrighi JF; Pion M; Wiznerowicz M; Geijtenbeek TB; Garcia E; Abraham S; Leuba F; Dutoit V; Ducrey-Rundquist O; van Kooyk Y; Trono D; Piguet V
J Virol; 2004 Oct; 78(20):10848-55. PubMed ID: 15452205
[TBL] [Abstract][Full Text] [Related]
58. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
Gropp M; Reubinoff B
Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
[TBL] [Abstract][Full Text] [Related]
59. High-efficient lentiviral vector-mediated gene transfer into primary human NK cells.
Micucci F; Zingoni A; Piccoli M; Frati L; Santoni A; Galandrini R
Exp Hematol; 2006 Oct; 34(10):1344-52. PubMed ID: 16982327
[TBL] [Abstract][Full Text] [Related]
60. Shuttle of lentiviral vectors via transplanted cells in vivo.
Blömer U; Gruh I; Witschel H; Haverich A; Martin U
Gene Ther; 2005 Jan; 12(1):67-74. PubMed ID: 15385952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
